Cost-effectiveness of epilepsy therapy: How should treatment effects be measured?

Epilepsia

Volumn 43, Issue SUPPL. 4, 2002, Pages 17-24

  Langfitt, John ^a   Wiebe, Samuel ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; OXCARBAZEPINE; VALPROIC ACID;

COST EFFECTIVENESS ANALYSIS; DISEASE ACTIVITY; EPILEPSY; HEALTH CARE; HEALTH CARE POLICY; HUMAN; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REVIEW;

EID: 0036279944     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.43.s.4.4.x     Document Type: Review

References (44)

1. The global burden of disease in 1990: Summary results, sensitivity analysis and future directions
2. The cost of epilepsy in the United States: An estimate from population-based clinical and survey data
3. Progress report on new antiepileptic drugs: A summary of the fourth Eilat conference (EILAT IV)
4. Preface
5. Assessing patient's utilities: Can the ends justify the means?
6. Why some health policies don't make sense at the bedside
7. Toward a broader view of values in cost-effectiveness analysis of health
8. Recommendations of the panel on cost-effectiveness in health and medicine
9. Antiepileptic drug treatment in rural Africa: Involving the community
10. Epilepsy and the quality of everyday life: Findings from a study of people with well-controlled epilepsy
11. Health-related quality of life and seizure control in temporal lobe epilepsy
12. The constitution of the World Health Organization
13. The MOS 36-item Short-Form Health Survey (SF-36), I: Conceptual framework and item selection
14. The Sickness impact profile: Development and final revision of a health status measure
15. An objective method for the assessment of psychological and social problems among epileptics
16. Development of the quality of life in epilepsy inventory
17. The initial development of a health-related quality of life model as an outcome measure in epilepsy
18. Multiattribute utility function for a comprehensive health status classification system: Health Utilities Index Mark 2
19. Modeling valuations for EuroQol health states
20. Methods for quality adjustment of life years
21. Quality-adjusted life years, utility and healthy-year equivalents
22. An alternative to QALYs: The saved young life equivalent (SAVE)
23. Quantifying the burden of disease: The technical basis for disability-adjusted life years
24. Measurement of health state utilities for economic appraisal: A review
25. The EuroQoL Instrument: An index of health-related quality of life
26. A scale of valuations of states of illness: Is there a social consensus?
27. A fifteen-dimensional measure of health-related quality of life (15-D) and its applications
28. Multi-attribute health status classification systems
29. A general health policy model: Update and applications
30. Large-scale health outcomes evaluation: How should quality of life be measured? Part I: Calibration of a brief questionnaire and a search for preference subgroups
31. The assessment of quality of life (AQoL) instrument: A psychometric measure of health-related quality of life
32. A review of the use of health status measures in economic evaluation
33. Predicting quality of well-being scores from the SF-36: Results from the Beaver Dam health outcomes study
34. Deriving a preference based single index from the UK SF-36 Health Survey
35. Adjunctive lamotrigine therapy in patients with refractory seizures: A lifetime cost-utility analysis
36. Quality of life in epilepsy: Comparison of four preference measures
37. Utility scores for chronic conditions in a community-dwelling population
38. Commission on outcome measurement in epilepsy 1994-1997: Final report
39. Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life
40. Comparison of the psychometric characteristics of three quality of life measures in intractable epilepsy
41. Outcome assessment in epilepsy: Comparative responsiveness of quality of life and psychosocial instruments